斯皮罗诺拉克与比卡胺在女性发型脱发:一个随机临床试验
Abhijeet Kumar Jha1, Md Zeeshan1, Anupama Singh1
1Department of Dermatology & STD, Patna Medical College & Hospital, Patna, India.
Clinical and experimental dermatology
|February 26, 2026
概括
比卡尔胺在治疗女性发型脱发 (FPHL) 时,与螺旋拉克相比,在三角镜上表现出更好的改善. 然而,临床终点在两种抗雄激素疗法之间没有显著差异.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 三学是指三学的学科.
背景情况:
- 抗雄激素治疗对于控制女性发型脱发 (FPHL) 至关重要.
- 对于常用的药物,如螺旋和双胺,存在有限的比较疗效数据.
- 这项研究解决了在FPHL治疗中需要直接比较双胺和螺旋乳的需求.
研究的目的:
- 为了比较双胺 (50毫克/天) 与螺旋 (100毫克/天) 单疗法在FPHL妇女的疗效和安全性.
- 评估三镜变化,包括毛发密度和轴径.
- 评估两种治疗方法的临床结果和安全性.
主要方法:
- 一项随机,双盲,并行组临床试验,涉及204名患有FPHL的女性 (18-50岁).
- 参与者每天服用100毫克的螺旋龙或每天服用50毫克的双胺口服24周.
- 在基线和24周进行了三光镜评估和临床评估.
主要成果:
- 比卡卢胺在额头部和顶部部位的毛发数量明显增加,相比于螺旋乳 (P < .001和P = .028,分别).
- 头发轴直径在两个头皮部位 (P < .001) 增加比卡胺更显著.
- 11.7%的比卡胺使用者报告了不良事件,而斯皮罗诺拉克使用者报告了18.6%.
结论:
- 比卡胺在FPHL中产生了优异的三光学改善,与螺旋拉克相比.
- 两组治疗群体之间在临床终点上没有发现显著差异.
- 局限性包括短期后续,单中心设计和每个协议的分析,影响概括性.
相关概念视频
Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Bioequivalence studies: Biowaivers
332
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
332
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
338
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
338


